Actigen

Delivering medicines that improve outcomes and quality of life for patients

[Actigen @Actigenltd]

We're excited to share the news that our brand new website is LIVE! 💻
This is a big step for us to help achieve our goals in 2022 and beyond.
To find out more about Actigen and what we are looking to achieve, head to the link below! ⤵️

https://t.co/nS8NoCKa6A

#RareDiseases

[Actigen @Actigenltd]

Amazing news from @GenomicsEngland and @NHSuk! Early detection in #rarediseases is crucial and can change the lives of many children by accelerating diagnosis and access to treatments. We’ll be following the results of the study with interest. https://t.co/FPAVUnKEoo

[Actigen @Actigenltd]

Thank you to everybody we spoke to at #BioEquity Europe – we had a fantastic couple of days! If we didn’t see you at the conference, you can still book a virtual meeting on the PartneringONE platform. #Partnering #DrugDevelopment #Investment

[Actigen @Actigenltd]

It’s MPS Awareness Day and we’d like to take a moment to highlight the incredible work of @MPSSocietyUK. Over 10 years of supporting families affected by rare genetic conditions.

To find out more, head to their website https://t.co/JFMlvoZ4AO. #MPSAwarenessWeek

[Actigen @Actigenltd]

We’re here in San Sebastian for #BioEquity Europe! It’s not too late to book a meeting with Michael Braunagel to discuss partnership opportunities. We look forward to connecting with you over the next few days. #Partnering #DrugDevelopment

[Actigen @Actigenltd]

It’s MPS Awareness Week and we're supporting the @MPSSocietyUK’s aim to encourage people to think about those affected by mucopolysaccharidoses (MPS).

To find out more, head to their website https://t.co/JFMlvoZ4AO #MPSAwarenessWeek

[Actigen @Actigenltd]

Just one week until we arrive in San Sebastian for #BioEquity Europe. Don’t miss your opportunity to discuss partnering opportunities with our Managing Director, Michael Braunagel. #Partnering #DrugDevelopment #Investment

[Actigen @Actigenltd]

We’re excited to announce that our Managing Director, Michael Braunagel, will be attending #BioEquity Europe in San Sebastian this month. Will we see you there? Schedule a meeting with us via PartneringONE #Partnering #DrugDevelopment #Investment

[Actigen @Actigenltd]

Thank you to everyone who made the 17th #InternationalSymposiumOnMPSAndRelatedDiseases a resounding success! We’re inspired by all we learned, and excited to continue our efforts in advancing research and treatment for MPS and related rare diseases. Until next time!

[Actigen @Actigenltd]

The 17th #InternationalSymposiumOnMPSandRelatedDiseases is in full swing! We’re beyond impressed with the numerous scientific lectures and engaging workshops we’ve witnessed so far. If you’re attending too, we’d be delighted to connect with you – reach out to us today.

[Actigen @Actigenltd]

We're excited to attend the 17th #InternationalSymposiumOnMPSAndRelatedDiseases later this week. Ready to join the vital conversation on advancing research and treatment in MPS and related diseases alongside doctors, patients, families, scientists, and industry professionals.

[Actigen @Actigenltd]

Thank you @biztradegovuk and @CORDChina, joint hosts of this year’s Rare Disease Symposium. Along with our own Managing Director, Michael Braunagel, delegates and guest speakers from across the globe joined the summit. An excellent way to raise global attention to rare diseases.

[Actigen @Actigenltd]

Last week our Managing Director, Michael Braunagel, attended the UK-China Rare Disease Symposium, highlighting critical areas for global collaboration in #raredisease research and treatment. Thanks to all organisers and attendees - it was incredible to connect with you all!

[Actigen @Actigenltd]

Yesterday was #RareDiseaseDay and our Managing Director took to the stage at the UK-China Rare Disease Symposium. What a great opportunity to talk about how we tackle rare disease challenges globally.

[Actigen @Actigenltd]

We’re excited to attend the FDA's virtual meeting today for #RareDiseaseWeek! The event brings together patients, HCPs and industry leaders to discuss crucial topics in #rarediseaseresearch. Looking forward to all the valuable insights coming from the event.

[Actigen @Actigenltd]

It's @rarediseaseday and at Actigen, we're proud to be working in rare diseases. We’re committed to working with patients, partners and stakeholders to improve health equality for those who need us the most. #RareDiseaseDay

[Actigen @Actigenltd]

Join our Managing Director, Michael Braunagel, as he shares his insights on #rarediseaseadvancements at the UK-China Rare Disease Symposium. The panel is an opportunity to hear from industry leaders discussing access to innovative treatments worldwide for #rarediseases.

[Actigen @Actigenltd]

Our Managing Director, Michael Braunagel, has arrived in Shanghai ahead of the UK-China Rare Disease Symposium. If you’d like to reach out before the symposium, we’d be delighted to hear from you: https://t.co/C33x4rVJ0H

[Actigen @Actigenltd]

Our MD, Michael Braunagel, will be participating in the UK-China Rare Disease Symposium next week. This event is crucial in fostering international collaboration to tackle #rarediseases head-on. We're proud to be part of the conversation shaping the future of #healthcare

[Actigen @Actigenltd]

We’re delighted to see #RareX2024 taking place this week. From patients to policymakers, RareX unites the #raredisease community to advocate for improved treatment access and equity. We’re looking forward to hearing the insights coming out of the conference as it unfolds.

[Actigen @Actigenltd]

What a fantastic few days at #WORLDSymposium24! Great to attend and hear the latest developments in the field of #lysosomalstoreagediseases. Contact us if you want to learn more about the work we do in #rarediseases: https://t.co/dyIVv4Vmwj